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Background 
External ventricular drainage (EVD) systems 
are used as temporary measures to provide 
reliable means of monitoring intracranial pres-
sure (ICP) and controlling hydrocephalus 
(Arabi, Memish, Balkhy, Francis, Ferayan, 
Shimemeri & Almuneef, 2005). Hydrocepha-
lus can be a common problem which occurs 
in neurosurgical patients (Arabi et al, 2005). 
The risk factors associated with developing 
external drainage related bacterial meningitis 
(ED-BM) are duration of drainage and drain 
related factors such as site leakage or fre-
quent manipulation of the drain (Lopez-
Cortes, Marquez-Arbizu, Jiminez-Mejias, Ca-
ballero-Granado, Rey-Romero, Polaina & 
Pachon, 2000). In order to obtain a diagnosis 
of ED-BM in patients with external drainage 
systems, routine analysis of cerebrospinal 
fluid (CSF) is performed. A diagnosis of bac-
terial meningitis can be made if there is an 
increased leukocyte count, high protein con-
centration and low glucose concentration 
(Shameen, Vinod-Kumar & Neelagund, 
2008). It is currently unknown whether CSF  
analysis can be used to diagnose bacterial  
meningitis in patients undergoing EVD sys-
tem usage or whether external factors influ-
ence the results. However, studies have 
found it difficult to make a comparison of the 
CSF of patients with EVDs, and those without 
EVDs due to the underlying disease 
(Blomstedt, 1987).  
Micro-biological tests remain the gold stand-
ard for diagnosing ED-BM, however it is time 
consuming compared to leukocyte count and 
chemical analysis. CSF samples are collect-
ed routinely from EVD systems for laboratory 
tests. There have been several studies con-
ducted that discuss the correlation between 
sampling and infection rate (Crane & King, 
2015). However, there have been few studies 
conducted to identify the most appropriate 
site for cerebrospinal fluid collection in order 
to reduce the disruption of the closed EVD 
system and reduce the risk of infection. It is 
also controversial whether regular changes of 
EVDs can reduce CSF infection (Crane & 
King, 2015; Wong, 2011). 
Discussion: Cerebrospinal Fluid Sampling 
To investigate the value of several commonly 
used parameters for prediction and diagnosis 
of ED-BM in the literature of Rogier, Schade, 
Janke, Freek, Roel, Ronald, Gesku, Leo, 
Marc, Van Dijk, Joan, Voormolen, Hans & 
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Kuijper, (2006), a cohort study was per-
formed in 230 patients who had EVDs to ana-
lyse the predictive and diagnostic value of 
routine CSF sampling. Daily CSF samples 
were obtained for analysis and the results 
have shown that leukocyte count, glucose 
and protein concentrations in the CSF of 
EVDs with ED-BM were comparable to those 
of patients with external drains without ED-
BM in both groups. The results of CSF have 
shown that they were heterogeneous during 
the period of external drainage (Rogier, et al, 
2006). Results of patients with ED-BM during 
the first days of infection were compared with 
the results of the control group without ED-
BM; there were no statistical significant differ-
ences. The results were the same with CSF 
obtained in patients with ED-BM for the three 
days preceding an active infection when 
compared with the control group. 
Evidence points out that the CSF contents of 
patients who have recently undergone neuro-
surgery are often abnormal (Forgacs, Geyer 
& Freidberg, 2001). The chemical irritation 
resulting from the presence of blood products 
in the CSF leads to chemical or aseptic men-
ingitis and disturbs the glucose and protein 
concentration in CSF. It also increases CSF 
white blood cell count (Forgacs, et al, 2001). 
As the blood is reabsorbed from the CSF and 
infection subsides, chemical disturbances 
normalise in patients with EVDs that do not 
develop bacterial meningitis. Therefore, it is 
expected that CSF parameters will improve 
during the period of external drainage in   
patients who do not develop meningitis 
(Forgacs, et al, 2001). 
When analysing the results for the 200 pa-
tients with EVDs who did not have ED-BM as 
a reference, it was found that only a small 
proportion of patients who developed ED-BM 
had abnormal values for one of the common-
ly analysed CSF parameters shortly before or 
during the course of ED-BM infection. This 
led to the conclusion that combining the re-
sults for different CSF parameters did not 
increase the diagnosis value of CSF analysis 
(Rogier, et al, 2006). However this reference 
has not fully analysed the predictive value for 
ED-BM. 
Daily analysis of CSF was performed on 130 
patients in the literature by Pfisterer, 
Muhlbauer, Czech & Reinprecht, (2003). The 
leukocyte count for both control group and 
patient group was found to be heterogene-
ous. There was no difference in leukocyte 
count between the patients with ED-BM and 
patients without ED-BM. However the litera-
ture does not state whether glucose and pro-
tein were analysed in the report. 
To assess possible causes of risk factors for 
infection related to external ventricular drain-
age, a study was carried out by Hoefnagel & 
Dammers, (2008). The method involved two 
hundred and twenty eight patients in the peri-
od from January 1993 until April 2005 (over a 
12 year period). Reviews were collected cov-
ering patient information, including disease 
demographics, external ventricular drain data 
and infection occurrence. The data was com-
pared and included in a risk analysis study.  
Results of this study have shown that the 
mean age was 56 years. Analysis of both 
sexes has shown equal distribution. Most 
indications for insertion of EVD systems were 
for hydrocephalus caused by intraventricular 
haemorrhage which accounted for 48% of 
patients. Infection rate was 23.3% and the 
authors found that duration of the EVD sys-
tems was a risk factor for infection. Frequen-
cy of CSF sampling was also a risk factor for 
infection. The results indicate that there was 
a relatively high percentage of EVD-related 
infection (Hoefnagel & Dammers, 2008). Lim-
itations to the study included selection bias 
and some missing values. 
However, further analysis supported a rela-
tionship between the drain duration and fre-
quency of CSF sampling. The risk for infec-
tion increases with the duration of the drain, 
hence it has been suggested that sampling of 
CSF should be done less frequently (Schade, 
Schinkel, Visser, Van Dijk, Voormolen & Kui-
iper, 2005).These studies lend support for the 
development of protocols for EVD manage-
ment to reduce infection.  
Discussion: Drain Duration 
The most common complication of EVD sys-
tems is CSF infection (Kim, Uttley, Bell, 
Marsh, Moore, 1995). Neurosurgical patients 
with EVDs are at high risk for developing de-
vice related nosocomial infections (Lopez, et 
al, 2000). The use of closed drainage sys-
tems may decrease the rate of infection 
(Lucey & Myburgh, 2003). Efforts must be 
made to distinguish clinically relevant CSF 
infections from contamination and catheter 
colonisation (Lozier, Sciacca, Romagnoli & 
Connolly, 2002). Infection may lead to remov-
al and replacement of a new EVD system. 
Predisposing patient factors associated with 
high risk of infection include craniotomies, 
depressed skull fractures, intraventricular 
haemorrhages, catheter duration, catheter 
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irrigation, site leaks and frequent sampling of 
CSF (Korineck, Reina, Boch, Rivera, De Bels 
& Puybasset, 2005).   
Mayhall, Archer, Lamb, Spadora, Baggett, 
Ward & Narayan (1984), recommend elective 
revision of external ventricular drainage sys-
tem on day five post insertion to reduce the 
risk of infection. However, other larger stud-
ies have revealed that the duration of the 
EVD in a patient has no effect on the risk of 
infection (Lo, Spelman, Bailey, Cooper, 
Rosenfeld & Brecknell, (2007). To evaluate 
the roles of duration a catheter remained in-
serted and that of multiple catheter insertions 
in the literature of Lo, et al, (2007), a study 
was carried out at the Alfred Hospital in Vic-
toria, Australia. Data was obtained for pa-
tients who had undergone EVD system 
placement between the period of October 
2002 and May 2004 from the intensive care 
database. A record was kept for each patient, 
including age, conscious state, diagnosis, 
presence or absence of an open skull frac-
ture, diabetes mellitus status and bacterae-
mia within fourteen days of EVD insertion. 
The outcome measure of death prior to dis-
charge was also recorded. 
Results have shown that there were two hun-
dred patients who had EVD systems inserted 
during this period whilst in the intensive care 
unit. This group of patients had a mean age 
of 41 years (ranging from15-87 years). Sev-
enty-four per cent had traumatic brain inju-
ries; nineteen per-cent of these patients had 
open skull fractures. The remaining patients 
had presented with spontaneous subarach-
noid or intraventricular haemorrhage. None of 
these patients had a primary diagnosis of 
intracranial or spinal sepsis or any recorded 
infection within fourteen days of admission.  
In these patients, twenty one had nosocomial 
EVD-associated CSF infections. Five patients 
had positive cultures for infection in their CSF 
but no other evidence of infection was con-
sidered for colonisation of the EVDs. Diabe-
tes, patient’s age and the presence of a skull 
fracture did not present any significant risk 
factors for infection (Lo, et al, 2007). 
The literature is conflicting as to whether 
drain duration increases risk of EVD associ-
ated infections (Pfisterer, et al, 2003). This is 
reported by Sundberg, Kjellquist, Lumberg & 
Ponte, (1972) and has not changed since 
that period. They analysed 1586 patients and 
found that prolonged drain insertion was not 
a risk factor. Routine changing of EVD cathe-
ters after five days did not reduce the risk of 
CSF infection and did not improve outcome 
(Winfield, Rosenthal, Kanter & Casella, 
1993). 
However, the work by Mayhall, et al, (1984) 
presents a stark contrast to these findings. 
Despite these disagreements, there has been 
agreement that EVD- associated CSF infec-
tion is often acquired at the time of insertion 
when skin organisms enter the sterile intra-
cranial compartment (Khanna, Rosenblum, 
Rock & Malik (1995). Retrograde colonisation 
may also occur as a result of continued exter-
nalisation of the cerebrospinal space during 
sampling (Khanna, et al, 1995). 
Conclusion 
Study results have shown that frequent anal-
ysis of CSF has no predictive value for ED-
BM. Routine chemical analysis of CSF sam-
ples to screen patients with EVDs for ED-BM 
has shown no additional value. The analysis 
of an isolated CSF sample in a patient in 
whom ED-BM is suspected also has no addi-
tional value due to unclear cut-off levels. This 
lends support to diagnosis of ED-BM based 
only on the results of microbiological cultures 
It may be worthwhile to reduce the frequency 
of CSF sampling on patients with EVDs. The 
risk for infection increases with the duration 
of the drain, hence it has been suggested 
that sampling of CSF should be done less 
frequently. 
It has been proven in the literature reviewed 
that there is a well-established relationship 
between the duration of EVDs and the occur-
rence of EVD-related infections. Studies have 
shown that using standard protocols helps to 
reduce the rate of infection. Using closed 
drainage systems may also decrease the rate 
of infection. Sample size has not been men-
tioned in the results and this may be a limita-
tion of the literature. Routine CSF sampling 
should be avoided, unless there is suspicion 
of infection, in the presence of fever of un-
known origin or mental status change.  Multi-
ple external drain insertion is associated with 
an increase in infection rate. This practice 
should be abandoned. There has not been 
much change in the technique of EVDs 
throughout the years, hence earlier literature 
still applies.  From a nurse’s perspective, a 
standard protocol for clinically managing EVD 
systems should be established and no rou-
tine CSF samples should be undertaken un-
less necessary. The EVD system should also 
be handled under strict aseptic practice. 
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Introduction 
Leptomeningial carcimomatosis (LC) was 
first identified in the 1870 by Ebert in a pa-
tient with lung cancer, and was named in 
1902 by Sieffert as meningitis carcinomatosa 
(Schiff, Kesari & Wen, 2008). Sixteen thou-
sand patients globally will be diagnosed with 
LC each year (Abrey, 2002). There has been 
a significant rise in the incidence of LC since 
1970, thought to be due to improvements in 
the diagnostic techniques and neuro imaging 
available in today’s healthcare system 
(Schiff, Kesari & Wen, 2008). The rise in di-
agnosis is the direct result of patients surviv-
ing their primary cancer. Hence there is a 
need for health professionals to be aware of  
LC and the clinical presentation, in order to  
provide appropriate care and interventions 
along with the potential for future research 
and cure.  
Currently epidemiological studies suggest 
that 3-8% of patient with solid tumours will 
develop leptomeningeal metastasis (LM) 
throughout their illness (Abrey, 2002). Twen-
ty per cent of patients are diagnosed on au-
topsy. These are patients undiagnosed and 
asymptomatic (Le Rhun, Taillibert & Cham-
berlain, 2013).  It was determined that the 
rise in diagnosis is due to increased survival 
rates of cancer as a result of improved medi-
cal treatment. All cancers have the potential 
to metastasise into the meninges causing 
LM. The leading primary cancers associated 
with LM include lung cancer (10-26%), mela-
noma (5-25%), gastrointestinal (4-14%), can-
cer of unknown primary (1-7%) and breast 
cancer (12-35%)  (Le Rhun et al 2013). 
Abstract 
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The brain and spinal cord are surrounded by 
three membranes referred to as the menin-
ges, composed of the dura mater being the 
pachymeninges, arachnoid mater and pia 
mater referred to as the leptomeninges. The 
space between is referred to as the sub-
arachnoid space, containing the CSF and the 
Circle of Willis providing arterial blood supply. 
Approximately 140ml of cerebral spinal fluid 
surround the brain and spinal cord at any one 
time, replenishing approximately five times a 
day (Hickey, 2014). CSF is produced in the 
choroid plexus of the third, fourth and lateral 
ventricles. Tumours cells gain entry into the 
CSF and subarachnoid space by metastatic 
seeding. Entry is gained by hematogenous 
spread to the choroid plexus onto the lep-
tomeninges, primary hematogenous metasta-
sis through leptomeningeal vessels, metasta-
sis from the Batson venous plexus, retro-
grade dissemination, centripetal extension or 
direct extension from contiguous tumour de-
posits (Gleissner & Chamberlain, 2006; Le 
Rhun et al 2013). Once tumour cells have 
invaded the leptomeninges, the flow of CSF 
causes the seeding and infiltration of tumour 
cells in a diffuse and multifocal manner (Le 
Rhun et al 2013). Greatest infiltration occurs 
in the basal cisterns and dorsal surface of the 
spinal cord and cauda equina.  
Case Study 
Patient X presented to hospital with in-
creased confusion, ataxia and lower limb mild 
weakness. Histology included breast cancer 
where a left mastectomy and lymph node 
clearance was completed in the 14 months 
prior to diagnosis. Symptoms of leptomenin-
geal metastases are caused by pressure 
from the metastases placed on the nerves 
that run across the meninges in both the 
head and the spine. This includes those run-
ning from the spinal cord out to the body, and 
is dependent on the location of the metasta-
ses. Symptoms that occur simultaneously in 
both the head and the spine suggest a diag-
nosis of leptomeningeal metastases (LM). 
Leptomeningeal metastases can also cause 
hydrocephalus, a condition that occurs when 
the metastatic cancer interferes with the flow 
of cerebrospinal fluid around the brain. As the 
spinal fluid continues to be produced, an in-
crease in the intracranial pressure is then 
seen as the arachnoid villi are no longer able 
to effectively reabsorb the CSF. 
Clinical presentation occurs in a pleomorphic 
and multifocal manner with neurological signs 
and symptoms emerging over days to weeks. 
Symptoms correlate to the region of malig-
nant cell infiltration in the central nervous 
system (CNS). The clinical manifestation of 
LM can be caused by several different patho-
physiological mechanisms and can be char-
acterised into the following main categories: 
 cerebral hemisphere dysfunction caus-
ing a mass effect due to the invasion of
the leptomeninges and associated in-
flammation thus a raised intracranial
pressure (ICP) and occlusion of CSF
flow occurs.
 cranial nerve and spinal cord symp-
toms: Through direct involvement of
the tumour.
 exiting nerve roots (Demopoulos &
Brown, 2014; Drappatz & Batchelor,
2007; Hickey, 2014).
A recent study described the signs and 
symptoms of 150 patients with solid tumour 
LM (Clarke, Perez, Jacks, Panageas & 
DeAngelis, 2010; Clarke 2012; Demopoulos 
& Brown, 2014). Between 30-50% of patients 
describe headache as their initial symptoms 
(see Table 1). Headaches can be associated 
with raised ICP or meningeal irritation result-
ing in neck stiffness and pain, along with 
signs of nuchal rigidity. Headaches occurring 
due to a raised ICP are known to be associ-
ated with nausea, vomiting and dizziness. 
Table 1 (Above): Initial symptoms of LM as reported by patients. 
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These symptoms commonly occur in wave 
patterns caused by changes in position due 
to arachnoid villi failing to reabsorb CSF thus 
resulting in hydrocephalus. Altered mental 
status accounts for 11% of presenting symp-
toms with confusion, forgetfulness, disorien-
tation, lethargy or personality changes the 
most common. These changes in mental 
state are referred to as an encephalopathy, 
the result of hydrocephalus, seizure activity, 
cerebral dysfunction or a combination of 
those. When cranial nerves are directly in-
vaded by malignant cells within the subarach-
noid space, cranial neuropathy occurs.  
The first intervention in diagnosis is a lumbar 
puncture to obtain a CSF specimen. Malig-
nant cells are detected in 70-89% of CSF 
specimens (Le Rhun et al, 2013). Repeated 
samples are often necessary as only 50% of 
patients with LM on initial lumbar puncture 
exhibit positive cytology. Patients are 25% 
more likely to have positive cytology on se-
cond lumbar puncture. Multiple lumbar punc-
tures are often required due to the meningeal 
dissemination, where tumour cells are local-
ised in the brain rather than the spinal cord 
hence movement of CSF must occur in order 
to obtain a positive sample. Therefore nega-
tive CSF cytology is directly related to the 
flow of malignant cells within the spinal cord 
CSF when lumbar punctures are taken.  
Clinical finding on CSF analysis includes, an  
elevated opening pressure of > 200mm Hg in 
57% of patients,  decreased glucose concen-
tration, high protein concentration, lympho-
cytic pleocytosis and a positive cytology for 
malignant cells (Chamberlain, 2008; 
Drappatz & Batchelor, 2007; Palma, Fernan-
dez-Torron, Esteve-Belloch, Fontes-Villalba, 
Hernandez, Fernandez-Hidalgo, Gallego Pe-
rez-Larraya & Martinez-Vila, 2013). 
A positive MRI assessment of an undiag-
nosed patient includes a whole CNS scan 
where a complete neuraxis and A T1 C+ gad-
olinium enhancement is completed in order to 
obtain the primary diagnosis (Drappatz & 
Batchelor, 2007).  
Typical findings include a thin diffused en-
hancement along the contours of the gyri and 
sulci with multiple nodular deposits in the 
subarachnoid space in 30-50% of cases (Le 
Rhun et al, 2013). LM enhancement can be 
found in cerebellar folia, cortical surface, ba-
sal cisterns and ventral surface along the 
brainstem, indicating abnormal thickening 
and enhancement. However these are not 
the most common sites of LM.  Between 15-
25% of patients present with spinal enhance-
ment, showing linear or nodular enhance-
ment along the spinal cord or cauda equina 
where clumping of nerve roots can be seen 
(Le Rhun et al, 2013). CT is an uncommon 
practice due to poor diagnostic value, with 
significantly reduced sensitivities of 23-38% 
when compared with the MRI. 
Prognosis 
The overall prognosis for a patient with LM is 
poor; patients have an expected survival rate 
of 4-6 weeks if untreated and 4-6 months if 
treated. Research indicated that 14% of LM 
cases occur as a result of an advanced pri-
mary breast cancer with no well-established 
prognostic makers for patients with LM other 
than the presence of malignant cells within 
the CSF and low performance in Karnofsky 
performance status scale (Palma, et al 2013). 
Treatment 
Due to current poor prognostic outcomes, 
treatment aims to reduce mortality through 
improving and stabilising the patient’s neuro-
logical status, while maintaining neurological 
quality of life (Gleissner & Chamberlain, 
2006). Current treatment plans are com-
prised of intrathecal or systemic chemothera-
py and focal radiation therapy with the goal to 
reduce size of tumours and growth. Statisti-
cally 20% of patients who receive treatment 
will respond (Demopoulos & Brown, 2014; 
Palma et al, 2013). Suitable patients will un-
dergo insertion of a ventriculo-peritoneal 
shunt to alleviate hydrocephalus symptoms.  
Chemotherapy is the only treatment which 
allows for simultaneous treatment of the brain 
and spinal cord. Intrathecal administration is 
defined as injecting chemotherapy into a cer-
ebral- access device inserted surgically or via 
repeated lumbar punctures (Demopoulos & 
Brown, 2014). Intrathecal administration al-
lows for an even distribution throughout the 
subarachnoid space and is not required to 
cross the blood brain barrier (Drappatz & 
Batchelor, 2007). Access devices avoid the 
risk of epidural or subdural hematomas. 
Methotrexate and thiotepa are the most ef-
fective chemotherapies in the treatment of 
LM patients with metastasis from primary 
breast cancer (Demopoulos & Brown, 2014; 
Drappatz & Batchelor, 2007). Chemotherapy 
is administered initially twice weekly for three 
weeks then weekly for four week followed by 
monthly (Demopoulos & Brown 2014). 
Radiation therapy involves field radiotherapy 
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to symptomatic sites of the disease, bulky 
disease and sites where CSF flow is ob-
structed. The aim is to shrink tumour cells, 
stabilise neurological symptoms, establish 
CSF flow and relieve pain caused by radicu-
lopathies (Demopoulos, 2014).  
Nurses must consider the adverse effects of 
chemotherapy and radiation therapy. Admin-
istration of chemotherapy may result in raised 
ICP and impaired CSF flow. Nurses must 
observe for acute signs of fever, headache, 
nuchal rigidity, seizures, dizziness or blurred 
vision. Subacute signs include transverse 
myelitis, cranial nerve palsies, seizures or 
coma (Demopoulos, 2014). When administer-
ing radiation therapy the nurse should be 
aware of increased patient fatigue, changes 
in skin colour and flushing of skin along with 
skin tension and Lhermitte’s sign - an electri-
cal signal running from the back of the cervi-
cal spine to the tips of the feet, when the 
neck is bent forwards (Demopoulos, 2014). 
When selecting patient treatment options, 
chemotherapy or radiation therapy is consid-
ered and each play a significant role in the 
treatment of LM. Research indicates that in-
tra CSF chemotherapy is better on smaller 
LC tumours due to the thickness of cells and 
diffusion capacity (Demopoulos, 2014). Radi-
ation therapy is better at treating large bulky 
tumours and assisting in the restoration of 
CSF flow (Demopoulos, 2014). Combination 
therapy is currently the choice of treatment.  
Nurse’s Role 
When nursing a patient with LM the holistic 
approach is essential due to the array of 
symptoms a patient can display. Leg weak-
ness and difficulty walking are common 
symptoms, thus ongoing assessment of mo-
bility status including the need for walking 
aids, wheelchairs or hoisting devices. Refer-
ral to an occupational therapist before dis-
charge is also important. Regular speech and 
swallowing assessments should be per-
formed, as LM can increase the risk of aspi-
ration as cranial nerve deficits impair the abil-
ity to chew and swallow. Constipation is a 
significant issue for LM patients as de-
creased mobility, pain medications and 
chemotheraphy contribute to constipation 
(Drappatz & Batchelor, 2007). Nursing staff 
should commence a bowel regime including 
a high fibre diet, adequate oral intake and 
aperients. 
Conclusion    
As health professionals, it is important to note 
that in 3-8 % of patients with solid tumours, 
the chance of developing LM is a real consid-
eration. In Patient X’s case, due to a delayed 
diagnosis and intervention, prognosis and 
outcome was poor.  
MRI and lumbar puncture allows for earlier 
diagnosis and intervention, while chemother-
apy and radiation therapy improve longevity 
and quality of life.  Nurses are critical to the 
care of the LM patient. An understanding of 
the disease process and care required will 
ensure quality of life during the progression 
of the disease. With cancers increasing in 
today’s society and certain treatments readily 
available, health professionals will have an 
increased awareness of LM, therefore with 
the ability to  identify and treat earlier. 
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